Zenon Zenonos | Associate Director B-Cell Technology
AstraZeneca

Zenon Zenonos, Associate Director B-Cell Technology, AstraZeneca

Zenon is leading the B-Cell Technology Team at AstraZeneca in Cambridge. His team is specializing in antibody discovery using single-cell technologies. His work focuses on integrating wet lab and in silico approaches to accelerate therapeutic antibody lead generation. Zenon's research encompasses optimizing immunization strategies, developing automated high-throughput workflows, and applying computational methods to analyze B-cell repertoires for identifying high-quality antibody candidates.

Appearances:



Festival of Biologics Day 1 @ 17:50

Advancing Antibody Discovery Through Integrated single B-Cell Technologies

  • Immunisation strategies to maximise immune responses.
  • Leveraging single B-cell profiling to identify therapeutic antibody candidates.
  • Bridging experimental and computational antibody discovery through integrated wet lab and in silico pipelines.
last published: 28/Apr/26 15:45 GMT

back to speakers

Get involved at Festival of Biologics Basel 2026

 

 

TO SPONSOR


Derek Cavanagh

Derek.Cavanagh@terrapinn.com

 

Jack Bebb
Jack.Bebb@terrapinn.com

 

TO SPEAK


Jack Beard
Jack.Beard@terrapinn.com

 

MARKETING & PRESS


Ollie McDaid

ollie.mcdaid@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.